A phase 1/2, first-in-human study of STX-478 monotherapy or in combination with fulvestrant in patients with breast cancer or other advanced solid tumors (trial in progress)

被引：0
|
作者：
Montero, Alberto
Orr, Douglas
Munster, Pamela
LoRusso, Patricia
Jhaveri, Komal
Pluard, Timothy
Winer, Ira
Streit, Michael
Patterson, Monica
Roberts, Simon
Corsi-Travali, Stefani
Ewert, Courtney
Juric, Dejan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO1-20-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO1-20-04
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Phase 1 first-in-human trial of MTB-9655, the first oral inhibitor of ACSS2, in patients with advanced solid tumors.
    Perets, Ruth
    Geva, Ravit
    McKean, Meredith
    Goutopoulos, Andreas
    Erez, Omri
    Phadnis, Monica
    Youssoufian, Hagop
    Schwartz, Brian E.
    Kansra, Vikram
    Fattaey, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] A FIRST-IN-HUMAN PHASE I STUDY OF M6223 (TIGIT INHIBITOR) AS MONOTHERAPY OR IN COMBINATION WITH BINTRAFUSP ALFA IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED SOLID UNRESECTABLE TUMORS
    Watson, Geoffrey
    McKean, Meredith
    Tolcher, Anthony
    Victor, Anja
    Zhang, Sen
    Pierre, Vadryn
    Richter, Emilia
    Naing, Aung
    Naing, Aung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A561 - A561
  • [33] A first-in-human phase 1 dose-escalation and expansion study of intratumoral oncolytic reovirus (RC402) as a monotherapy or in combination with pembrolizumab in advanced solid tumors
    Voskoboynik, Mark
    Liu, Jia
    Song, Ki-Hoon
    Park, Dong-Guk
    Ryu, Min-Hee
    Chon, Hong Jae
    Kim, Chan
    CANCER RESEARCH, 2024, 84 (07)
  • [34] First-in-human trial of 4′-thio-2′-deoxycytidine (TdCyd) in patients with advanced solid tumors
    Coyne, G. O'Sullivan
    Chen, A.
    Kummar, S.
    Collins, J. M.
    Meehan, R. S.
    Suto, M.
    Rubinstein, L.
    Kinders, R.
    Moore, N.
    Parchment, R.
    Horneffer, Y.
    Juwara, L.
    Difilippantonio, M.
    Piekarz, R.
    Doroshow, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Phase 1 study of COM701 monotherapy and in combination with nivolumab in patients with advanced solid tumors
    Dumbrava, Ecaterina
    Fleming, Gini
    Hamilton, Erika
    Sullivan, Ryan
    Patnaik, Amita
    Papadopoulos, Kyriakos
    ElNaggar, Adam
    Hunter, John
    Olweny, Judy
    Adewoye, Adewoye
    Chmielowski, Bartosz
    Shepard, Dale
    Sharma, Manish
    Lim, Emerson
    Vaena, Daniel
    Rasco, Drew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [36] First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours
    Martin-Liberal, Juan
    Hollebecque, Antoine
    Aftimos, Philippe
    Jungels, Christiane
    Martin-Romano, Patricia
    Rodon, Jordi
    Kremer, Jill Dolores
    Zhang, Wei
    Bendell, Johanna
    BRITISH JOURNAL OF CANCER, 2020, 123 (08) : 1235 - 1243
  • [37] A phase 1, open-label, first-in-human study of TAS2940 in patients with advanced solid tumors
    Ahnert, Jordi Rodon
    Spigel, David R.
    Kremer, Jill
    Jin, Leah
    Benhadji, Karim Adnane
    Gil, Maciej
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] First-in-human trial of intravenous MEDI9253, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors
    Purroy, Noelia
    Durham, Nicholas
    Phillips, Marc
    Hattersley, Maureen M.
    Jung, Lindsey
    Davar, Diwakar
    Zamarin, Dmitriy
    Johanns, Tanner M.
    Puzanov, Igor
    CANCER RESEARCH, 2022, 82 (12)
  • [39] First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours
    Juan Martin-Liberal
    Antoine Hollebecque
    Philippe Aftimos
    Christiane Jungels
    Patricia Martin-Romano
    Jordi Rodon
    Jill Dolores Kremer
    Wei Zhang
    Johanna Bendell
    British Journal of Cancer, 2020, 123 : 1235 - 1243
  • [40] A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and-2 Inhibitor, in Patients with Advanced Solid Tumors
    Dowlati, Afshin
    Vlahovic, Gordana
    Natale, Ronald B.
    Rasmussen, Erik
    Singh, Indrajeet
    Hwang, Yuying C.
    Rossi, John
    Bass, Michael B.
    Friberg, Gregory
    Pickett, Cheryl A.
    CLINICAL CANCER RESEARCH, 2016, 22 (18) : 4574 - 4584
12345